OPHTHALMOLOGIC PREPARATIONS

Brand Owner (click to sort) Address Description
ATCERICH Kyoto Drug Discovery & Development Co.,Ltd. #302, Saito Bio Hills Center Japan Ophthalmologic preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for orthopaedic purposes; pharmaceutical preparations for use in urology; pharmaceutical preparations for treating respiratory diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; cytostatics for pharmaceutical purposes;
AVITEARS Pinnacle Science 1608 Almora Court Willow Springs NC 27592 Ophthalmologic preparations, namely, therapeutic eye drops;
BETIMOL AKORN OPERATING COMPANY 1925 West Field Court Lake Forest IL 60045 ophthalmologic preparations;
BETIMOL AKORN INTERNATIONAL S.A.R.L. 15 RUE EDWARD STEICHEN LUXEMBOURG L02540 Luxembourg ophthalmologic preparations;
BETIMOL SANTEN PHARMCEUTICAL CO., LTD. 3-9-19, Shimoshinjo, Higashiyodogawa-ku Osaka 5338651 Japan ophthalmologic preparations;
EVIVADROPS Eye Pharma S.p.A. Via Borghero, 9 I-16148 Genova GE Italy Ophthalmologic preparations; collyrium; pharmaceutical preparations for the treatment of eye diseases and conditions;
FLUORON Fluoron GmbH Magirus-Deutz-Strasse 10 Ulm 89077 Germany OPHTHALMOLOGIC PREPARATIONS;
FLUORON Fluoron GmbH Magirus-Deutz-Strasse 10 Ulm 89077 Germany ophthalmologic preparations; agents, namely, medical pastes used for wound dressing and wound sealing; agents, namely, medical silicon used in orthopedics for injection into joints; agents, namely, medical cleansing solutions used during endoscopy to enhance visualization; viscous agents, namely, topical gel for medical and therapeutic use, namely, ultrasound gel used in urology for enhancing visibility during operations; chemical products, in particular silicones, hydrocarbons and mixtures thereof, namely, functionalized silicones and aromatic hydrocarbons for use in the manufacture of medical compositions; chemicals, namely, fluorinated compounds in highly pure form, namely, fluorinated silicones, fluorinated hydrocarbons and mixtures thereof for use in the manufacture of medical compositions; chemicals, namely, hydrophilised and lipophilised silicones, hydrophilised hydrocarbons and mixtures of the aforementioned silicones and hydrocarbons for use in medical compositions; highly pure chemicals and mixtures for use in the manufacture of medical compositions; highly pure chemicals and mixtures thereof for preserving organs, namely, fluorinated compounds and dyes; dyes for visualizing cells in the human or animal body, namely, diazo dyes, triarylmethane dyes, anthraquinone dyes and fluorescent dyes; and highly pure liquid chemicals for use in the manufacture of medical compositions;surgical, medical, dental and veterinary instruments and apparatuses, namely, syringes, injection syringes for medical purposes; disposable syringes for medical purposes; reusable syringes for medical purposes; cannulas for medical purposes; and cylinders for injection syringes for medical purposes;
FLUORON Fluoron GmbH Magirus-Deutz-Strasse 10 Ulm 89077 Germany ophthalmologic preparations; agents, namely, medical pastes used for wound dressing and wound sealing; agents, namely, medical silicon used in orthopedics for injection into joints; agents, namely, medical cleansing solutions used during endoscopy to enhance visualization; viscous agents, namely, topical gel for medical and therapeutic use, namely, ultrasound gel used in urology for enhancing visibility during operations;
FLUORON Fluoron GmbH Magirus-Deutz-Strasse 10 Ulm 89077 Germany ophthalmologic preparations; agents, namely, medical pastes used for wound dressing and wound sealing; agents, namely, medical silicon used in orthopedics for injection into joints; agents, namely, medical cleansing solutions used during endoscopy to enhance visualization; viscous agents, namely, topical gel for medical and therapeutic use, namely, ultrasound gel used in urology for enhancing visibility during operations;
LIPOSAN Murray & Pool Enterprises Ltd. Victoria House, 26 Main St, Suites 41/42 Gibraltar Gibraltar Ophthalmologic preparations;
LUBRISTIL S.I.F.I. S.p.a. Via Ercole Patti, 36-Lavinaio Catania Italy Ophthalmologic preparations;
METICEL OFTENO LABORATORIOS SOPHIA, S.A. DE C.V. Av. Paseo Del Norte 5255 Guadalajara Technology Park Zapopan, Jalisco C.P. 45010 Mexico ophthalmologic preparations;
NAZIL OFTENO LABORATORIOS SOPHIA, S.A. DE C.V. Av. Paseo Del Norte 5255 Guadalajara Technology Park Zapopan, Jalisco C.P. 45010 Mexico Ophthalmologic preparations;
RETICEP Kyoto Drug Discovery & Development Co.,Ltd. #302, Saito Bio Hills Center Japan Ophthalmologic preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for orthopaedic purposes; pharmaceutical preparations for use in urology; pharmaceutical preparations for treating respiratory diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; cytostatics for pharmaceutical purposes;
SYLENTIS SYLENTIS, S.A.U. 5º Plaza del Descubridor Diego de Ordás, 3 Madrid E-28003 Spain Ophthalmologic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders;Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Research in the field of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy;
SYLENTIS SYLENTIS, S.A.U. 5º Plaza del Descubridor Diego de Ordás, 3 Madrid E-28003 Spain Ophthalmologic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; collyrium; ophthalmic preparations; medicated gels, creams and solutions for eye use; medicated eye drops; medicated eye lotions; medicated eye sprays; medicated eye ointments;Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Research in the field of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceutical preparations and medicines for the treatment of eye diseases and conditions; Development of pharmaceutical preparations and medicines for the treatment of ocular disorders or diseases; Testing, inspection, research, or development of pharmaceutical preparations for the treatment of eye diseases and conditions; Testing, inspection, research, or development of pharmaceutical preparations for the treatment of ocular disorders or diseases;
VISCKET Kyoto Drug Discovery & Development Co.,Ltd. #302, Saito Bio Hills Center Japan Ophthalmologic preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for orthopaedic purposes; pharmaceutical preparations for use in urology; pharmaceutical preparations for treating respiratory diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; cytostatics for pharmaceutical purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. There is provided an ophthalmologic apparatus which is easily operated. In the ophthalmologic apparatus, during measurement using an eye examination portion for measuring an optical characteristic of an eye to be examined, the eye examination portion is moved relative to the eye to be examined in up/down and left/right directions by manual input. Then, the eye examination portion is moved relative to the eye to be examined in a forward/backward direction by automatic control.